|
Volumn 22, Issue 14, 2014, Pages 3620-3628
|
Novel 3-arylfuran-2(5H)-one-fluoroquinolone hybrid: Design, synthesis and evaluation as antibacterial agent
|
Author keywords
3 Arylfuran 2(5H) one; DNA gyrase; Fluoroquinolone; Hybrid; Multi target; TyrRS
|
Indexed keywords
7 (4 (2 (3 (2 CHLOROPHENYL)FURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 (4 FLUOROPHENYL) 6 FLUORO 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 (2 CHLOROPHENYL)FURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 ETHYL 6 FLUORO 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 (2 FLUOROPHENYL)FURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 (4 FLUOROPHENYL) 6 FLUORO 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 (2 FLUOROPHENYL)FURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 CYCLOPROPYL 6 FLUORO 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 (2 FLUOROPHENYL)FURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 ETHYL 6 FLUORO 4 OXO 1,4 DIHYDRO 1,8 NAPHTHYRIDINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 (2 FLUOROPHENYL)FURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 ETHYL 6 FLUORO 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 (3 BROMOPHENYL)FURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 (4 FLUOROPHENYL) 6 FLUORO 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 (3 BROMOPHENYL)FURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 ETHYL 6 FLUORO 4 OXO 1,4 DIHYDRO 1,8 NAPHTHYRIDINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 (3 CHLOROPHENYL)FURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 (4 FLUOROPHENYL) 6 FLUORO 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 (3 CHLOROPHENYL)FURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 ETHYL 6 FLUORO 4 OXO 1,4 DIHYDRO 1,8 NAPHTHYRIDINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 (4 BROMOPHENYL)FURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 (4 FLUOROPHENYL) 6 FLUORO 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 (4 BROMOPHENYL)FURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 CYCLOPROPYL 6 FLUORO 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 (4 BROMOPHENYL)FURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 ETHYL 6 FLUORO 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 (4 CHLOROPHENYL)FURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 (4 FLUOROPHENYL) 6 FLUORO 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 (4 CHLOROPHENYL)FURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 CYCLOPROPYL 6 FLUORO 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 (4 CHLOROPHENYL)FURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 ETHYL 6 FLUORO 4 OXO 1,4 DIHYDRO 1,8 NAPHTHYRIDINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 (4 CHLOROPHENYL)FURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 ETHYL 6 FLUORO 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 (4 FLUOROPHENYL)FURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 (4 FLUOROPHENYL) 6 FLUORO 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 (4 FLUOROPHENYL)FURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 CYCLOPROPYL 6 FLUORO 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 (4 METHOXYPHENYL)FURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 CYCLOPROPYL 6 FLUORO 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 (4 METHYLPHENYL)FURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 (4 FLUOROPHENYL) 6 FLUORO 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 (4 METHYLPHENYL)FURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 CYCLOPROPYL 6 FLUORO 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 PHENYLFURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 (4 FLUOROPHENYL) 6 FLUORO 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 PHENYLFURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 CYCLOPROPYL 6 FLUORO 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 PHENYLFURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 ETHYL 6 FLUORO 4 OXO 1,4 DIHYDRO 1,8 NAPHTHYRIDINE 3 CARBOXYLIC ACID;
7 (4 (2 (3 PHENYLFURAN 2(5H) ONE 4 YLOXY)ETHYL)PIPERAZIN 1 YL) 1 ETHYL 6 FLUORO 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLIC ACID;
CIPROFLOXACIN;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANTIINFECTIVE AGENT;
FURAN DERIVATIVE;
QUINOLONE DERIVATIVE;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
BACILLUS SUBTILIS;
BACTERIAL STRAIN;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG DETERMINATION;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME ASSAY;
ESCHERICHIA COLI;
IC 50;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MINIMUM INHIBITORY CONCENTRATION;
MOLECULAR DOCKING;
NONHUMAN;
STRUCTURE ANALYSIS;
BACTERIA;
CHEMICAL STRUCTURE;
CHEMISTRY;
DOSE RESPONSE;
DRUG EFFECTS;
MICROBIAL SENSITIVITY TEST;
MULTIDRUG RESISTANCE;
STRUCTURE ACTIVITY RELATION;
SYNTHESIS;
ESCHERICHIA COLI;
NEGIBACTERIA;
POSIBACTERIA;
ANTI-BACTERIAL AGENTS;
BACTERIA;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG RESISTANCE, MULTIPLE, BACTERIAL;
FLUOROQUINOLONES;
FURANS;
MICROBIAL SENSITIVITY TESTS;
MODELS, MOLECULAR;
MOLECULAR STRUCTURE;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84902540245
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2014.05.018 Document Type: Article |
Times cited : (49)
|
References (28)
|